Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

April 8, 2019

Study Completion Date

April 8, 2019

Conditions
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Interventions
BIOLOGICAL

Fecal Microbiota Transplant (FMT)

The study intervention consists of frozen, bottled or encapsulated fecal microbiota preparations that have been screened and prepared to a uniform and rigorous standard by OpenBiome. FMT is performed by patients receiving a retention enema and swallowing capsules, introducing stool from a healthy donor into their intestinal tract.

BIOLOGICAL

Placebo

Placebo administration will consist of both a placebo retention enema and placebo capsules.

Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Stacy A. Kahn

OTHER

NCT02330653 - Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis | Biotech Hunter | Biotech Hunter